Cleared Special

K170966 - TONOPORT VI

K170966 is the FDA 510(k) clearance for TONOPORT VI by Par Medizintechnik GmbH & Co. KG. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Special 510(k) pathway after a 75-day FDA review.

K170966 · Par Medizintechnik GmbH & Co. KG · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2017
Decision
75d
Days
Class 2
Risk

K170966 is an FDA 510(k) clearance for the TONOPORT VI. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Par Medizintechnik GmbH & Co. KG (Berlin, DE). The FDA issued a Cleared decision on June 14, 2017 after a review of 75 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Par Medizintechnik GmbH & Co. KG devices

Submission Details

510(k) Number K170966 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 31, 2017
Decision Date June 14, 2017
Days to Decision 75 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 125d · This submission: 75d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 501
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K170966.
Microlife Upper Arm Automatic Digital Blood Pressure Monitor
K170467 · Microlife Intellectual Property GmbH · Aug 2017
BP5S Wireless Blood Pressure Monitor
K171062 · Andon Health Co, Ltd. · Aug 2017
Fully Automatic Blood Pressure Monitor
K171282 · Andon Health Co, Ltd. · Jul 2017
Fully Automatic Electronic Blood Pressure Monitor
K163276 · Andon Health Co, Ltd. · May 2017
HEM-9210T
K163235 · Omron Healthcare, Inc. · Apr 2017
Omron HEM-6400T-Z Wrist Blood Pressure Monitor
K163045 · Omron Healthcare, Inc. · Feb 2017